Ben Jones, vice president, Government Relations & Public Policy, McKesson Specialty Health, discusses the importance of capturing real-world evidence in electronic health records (EHRs) and challenges oncologists face when trying to obtain these data from EHRs.
Ben Jones, vice president, Government Relations & Public Policy, McKesson Specialty Health, discusses the importance of capturing real-world evidence in electronic health records (EHRs) and challenges oncologists face when trying to obtain these data from EHRs.
Transcript
How important is capturing real-world evidence in EHRs for improving the care of patients?
From a policy perspective, as all of these proposals come around, they have 1 central theme, and that is trying to drive towards value. Every policy maker wants to do 2 things: they want to increase coverage and reduce costs. That’s very difficult to do unless you can figure out how to drive efficiency and drive toward value. The only way to drive toward value is to make sure that we’ve got a good handle on patient data, and we see how we’re measuring outcomes. We see what’s working, we see what’s not working. We use all of these tools that we believe are driving value and we capture the data to make sure that’s actually the case. As that drive toward value continues, patient data is going to be very important.
Is this real-world evidence easily accessible currently, or are there challenges oncologists experience when trying to obtain these data from EHRs?
It’s still very difficult. Technology had progressed over the last decade by leaps and bounds. Unfortunately, the more desire there is to catch data, sometimes, often times, that means an increased burden from the provider’s perspective. So, there still is that barrier. I think everybody recognizes the value in data, the need and the necessity to gather data and have data that you can trust, that is fully in-depth enough to be of value down the road. The problem then becomes do we have the right systems in place to make sure that burden is not so much that we’re reducing the value of data down the road?
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More